ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
Author:
Affiliation:
1. Hematology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt
2. Chemical Pathology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt
Publisher
The Korean Society of Hematology
Subject
Hematology
Link
https://synapse.koreamed.org/pdf/10.5045/br.2019.54.1.57
Reference41 articles.
1. The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment
2. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
3. Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors
4. Long-term benefits of imatinib (IM) for patients newly diagnosed with chronic myelogenous leukemia in chronic phase (CML-CP): The 5-year update from the IRIS study
5. hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-25
2. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population;Cancer Chemotherapy and Pharmacology;2024-06-18
3. Lymphangiogenesis and Stem Cells in Hematological Malignancies;Comprehensive Hematology and Stem Cell Research;2024
4. A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients;Drug Research;2023-01-11
5. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer;Cancers;2020-09-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3